Literature DB >> 1690510

Chemically induced mammary gland adenomyoepitheliomas and myoepithelial carcinomas of mice. Immunohistochemical and ultrastructural features.

S Rehm1.   

Abstract

Myoepithelial cell tumors of the mammary gland have been observed in several mammalian species and are composed of a single cell type (myoepithelium) or, more often, present as a biphasic process including neoplastic ductal epithelial cells. In dogs, these are common tumors, but in humans they are rare neoplasms of the breast, and little is yet known of their pathogenesis, particularly with respect to myoepithelial origin. The present report describes bicellular mammary gland tumors arising from the duct epithelium that were induced in (C57BL/6NCr X DBA/2NCr)F1 (B6D2F1) mice by four weekly oral applications of 1 mg 7,12-dimethylbenz[a]anthracene (DMBA) starting at 8 weeks of age. Mammary tumors developed 7 to 8 months later in 14 of 57 mice, and most showed great morphologic resemblance to human adenomyoepitheliomas and myoepithelial carcinomas. Ultrastructurally, the induced tumors were composed of cuboidal epithelium with a microvillous border originating from the lining duct epithelium and plump oval or highly elongated cells that were identified as myoepithelial in origin. These spindle cells contained abundant microfilaments in parallel orientation, some with focal densities and intermediate filaments that frequently formed loose bundles or compact tonofibrils. The myoepithelial cells possessed well-developed desmosomes and plasma membrane caveolae and were regularly bordered by single or reduplicated basement membranes. By immunohistochemistry, strong immunoreactivity was observed for actin in the myoepithelial tumor component only, whereas cytokeratin was variably present in both duct epithelium and myoepithelium. Neoplastic myoepithelial cells stained purple with phosphotungstic acid hematoxylin (PTAH) and brilliant red with Masson's trichrome. It is suggested that DMBA-induced mouse mammary gland adenomyoepitheliomas and myoepithelial carcinomas may serve as very useful animal models to study myoepithelial tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690510      PMCID: PMC1877481     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Adenomyoepithelioma of the breast.

Authors:  M Jabi; I Dardick; N Cardigos
Journal:  Arch Pathol Lab Med       Date:  1988-01       Impact factor: 5.534

2.  Ultrastructural and histochemical demonstration of myoepithelium in mixed tumors of the canine mammary gland.

Authors:  L T Pulley
Journal:  Am J Vet Res       Date:  1973-12       Impact factor: 1.156

3.  Studies of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene administration.

Authors:  T M Murad; E Von Haam
Journal:  Cancer Res       Date:  1972-07       Impact factor: 12.701

4.  Morphological classification of mammary tumours in the mouse.

Authors:  W J Ebbenhorst Tengbergen
Journal:  Pathol Eur       Date:  1970

Review 5.  The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors.

Authors:  H Hamperl
Journal:  Curr Top Pathol       Date:  1970

6.  Classification of mouse mammary tumors in Dunn's miscellaneous group including recently reported types.

Authors:  B Sass; T B Dunn
Journal:  J Natl Cancer Inst       Date:  1979-05       Impact factor: 13.506

7.  Serial transplantation of chemical carcinogen-induced mouse mammary ductal dysplasias.

Authors:  D Medina
Journal:  J Natl Cancer Inst       Date:  1979-02       Impact factor: 13.506

8.  Role of antibody to S100 protein in diagnostic pathology.

Authors:  H J Kahn; A Marks; H Thom; R Baumal
Journal:  Am J Clin Pathol       Date:  1983-03       Impact factor: 2.493

9.  Abnormal deposition of basement membrane and connective tissue components in dimethylbenzanthracene-induced rat mammary tumours: an immunocytochemical and ultrastructural study.

Authors:  E J Ormerod; M J Warburton; B Gusterson; C M Hughes; P S Rudland
Journal:  Histochem J       Date:  1985-10

10.  Fine structure of murine mammary tumours: the relationship between epithelium and connective tissue in neoplasms induced by various agents.

Authors:  D Tarin
Journal:  Br J Cancer       Date:  1969-06       Impact factor: 7.640

View more
  7 in total

Review 1.  How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.

Authors:  Matthew R Swiatnicki; Eran R Andrechek
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-06-21       Impact factor: 2.673

2.  Hypoxia-induced nitric oxide release by luminal cells stimulates proliferation and uPA secretion of myoepithelial cells in a bicellular murine mammary tumor.

Authors:  Martin Alejandro Krasnapolski; Catalina Lodillinsky; Elisa Bal De Kier Joffé; Ana María Eiján
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-17       Impact factor: 4.553

3.  Mammary tumor suppression by transforming growth factor beta 1 transgene expression.

Authors:  D F Pierce; A E Gorska; A Chytil; K S Meise; D L Page; R J Coffey; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

4.  PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat.

Authors:  V Bhardwaj; D D Ankola; S C Gupta; M Schneider; C-M Lehr; M N V Ravi Kumar
Journal:  Pharm Res       Date:  2009-09-09       Impact factor: 4.200

5.  Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model.

Authors:  Viviana Bumaschny; Alejandro Urtreger; Miriam Diament; Martín Krasnapolski; Gabriel Fiszman; Slobodanka Klein; Elisa Bal de Kier Joffé
Journal:  Breast Cancer Res       Date:  2004-01-15       Impact factor: 6.466

6.  A spontaneous myoepithelial carcinoma in the mammary gland of an aged female ICR (CD-1) mouse.

Authors:  Tsuyoshi Ito; Toshinori Yoshida; Katsumi Soma; Yoshitaka Katoh; Yuko Shimada; Aya Ohnuma-Koyama; Naofumi Takahashi; Yoshimasa Okazaki; Atsushi Shiga; Maki Kuwahara; Takanori Harada
Journal:  J Toxicol Pathol       Date:  2017-04-27       Impact factor: 1.628

7.  The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.

Authors:  Bre-Anne Fifield; Ingrid Qemo; Evie Kirou; Robert D Cardiff; Lisa Ann Porter
Journal:  Breast Cancer Res       Date:  2019-12-11       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.